The report provides a detailed analysis essential for establishing a Valproic Acid production plant. It encompasses all critical aspects necessary for Valproic Acid production, including the cost of Valproic Acid production, Valproic Acid plant cost, Valproic Acid production costs, and the overall Valproic Acid production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Valproic Acid production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Valproic acid is a branched short-chain fatty acid that is used as an anticonvulsant and mood stabiliser. It is utilised in the treatment of epilepsy, like focal, generalised tonic-clonic, absence, and myoclonic seizures, as well as in bipolar disorder for managing manic episodes. It is also used for migraine prophylaxis and as an emergency treatment of status epilepticus, diabetic peripheral neuropathy, and postherpetic neuralgia. It works by enhancing GABA neurotransmission, blocking voltage-gated sodium and calcium channels, which contribute to its strong neuropharmacological effects. Its side effects include birth defects, hepatotoxicity, and neurotoxicity, which need careful monitoring in patients (especially women of childbearing age).
The global valproic acid market is driven by the growing cases of neurological disorders like epilepsy, bipolar disorder, and migraines. Also, a rise in awareness of mental health issues and expanding healthcare infrastructure worldwide further boost its market. The expiration of patents for original valproic acid formulations has increased demand for affordable generic variants, which has fuelled its market growth. The availability and production capacity of active pharmaceutical ingredients (APIs), along with strict regulatory compliance and quality standards, impact industrial valproic acid procurement. Other factors, like competitive pricing pressures among pharmaceutical companies and changes in raw material costs linked to its chemical precursors, affect its sourcing.
Raw Material for Valproic Acid Production
According to the Valproic Acid production plant project report, the key raw materials used in the production of Valproic Acid include 4-Heptanol-Hydrobromic Acid-Hydrogen Cyanide.
Production Process of Valproic Acid
The extensive Valproic Acid production cost report consists of the following major industrial production process:
- From 4-Heptanol and Hydrobromic Acid: The production process of Valproic acid involves several steps. First, 4-heptanol is reacted with hydrobromic acid (HBr) to convert it into 4-bromoheptane. After this, 4-bromoheptane is treated with hydrogen cyanide, which leads to a nucleophilic substitution reaction to form 4-cyanoheptane. Finally, 4-cyanoheptane goes through alkaline hydrolysis that converts the nitrile group into the corresponding carboxylic acid, which leads to the formation of valproic acid.
Valproic acid has a molecular formula of C8H16O2 and a molecular weight of 144.21 g/mol. It appears as a colourless to pale yellow viscous liquid with a faint, characteristic odour. It has a boiling point of around 220 degree Celsius and a flash point of 111 degree Celsius. Its specific gravity is about 0.922, which makes it less dense than water. It is slightly soluble in water but is freely soluble in organic solvents like acetone, chloroform, ether, and methanol. It is acidic because of its carboxyl group, and it goes through neutralisation reactions with bases, giving salts like sodium valproate. Its structure contains a carboxylic acid group and a branched alkyl chain, which contribute to its lipophilicity and mechanism of action in pharmacology.